Azithromycin News and Research

RSS
Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
UTHealth experts successfully treat 3-week-old infant with severe COVID-19

UTHealth experts successfully treat 3-week-old infant with severe COVID-19

COVID-19 can trigger serious inflammatory-related cardiovascular problems

COVID-19 can trigger serious inflammatory-related cardiovascular problems

Early Heparin therapy improves hypoxia in COVID-19 patients

Early Heparin therapy improves hypoxia in COVID-19 patients

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

Is hydroxychloroquine effective against COVID-19?

Is hydroxychloroquine effective against COVID-19?

Hydroxychloroquine and azithromycin treatment in 80 COVID-19 patients: short-term outcomes

Hydroxychloroquine and azithromycin treatment in 80 COVID-19 patients: short-term outcomes

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

Cost of ‘repurposing’ existing drugs to treat COVID-19

Cost of ‘repurposing’ existing drugs to treat COVID-19

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Potential harms associated with some drugs used for treating COVID-19 patients

Potential harms associated with some drugs used for treating COVID-19 patients

ATS releases new guidance to help clinicians manage COVID-19 patients

ATS releases new guidance to help clinicians manage COVID-19 patients

Who should be taking antimalarial drugs as treatment against COVID-19?

Who should be taking antimalarial drugs as treatment against COVID-19?

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Study finds no benefit in using broad-spectrum antibiotics as initial pneumonia treatment

Study finds no benefit in using broad-spectrum antibiotics as initial pneumonia treatment

Macrolide, penicillin antibiotics in pregnancy could affect children’s health

Macrolide, penicillin antibiotics in pregnancy could affect children’s health

Study pinpoints a gene that allows chlamydia to pick up DNA from host environment

Study pinpoints a gene that allows chlamydia to pick up DNA from host environment

New clinical practice guideline published for adults with community acquired pneumonia

New clinical practice guideline published for adults with community acquired pneumonia